Article
RANKL and RANK: From Mammalian Physiology to Cancer Treatment.
Trends in cell biology - 1 Mar 2018
Rao Shuan, Cronin Shane J F, Sigl Verena, Penninger Josef M
Abstract excerpt
The tumor necrosis factor (TNF) receptor RANK (TNFRSF11A) and its ligand RANKL (TNFSF11) regulate osteoclast development and bone metabolism. They also control stem cell expansion and proliferation of mammary epithelial cells via the sex hormone progesterone. As such, RANKL and RANK have been implicated in the onset of hormone-induced breast cancer. Recently, RANK/RANKL were identified as crucial regulators for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
